Freeny P C, Hauptmann E, Althaus S J, Traverso L W, Sinanan M
Department of Radiology, University of Washington School of Medicine, Seattle 98195, USA.
AJR Am J Roentgenol. 1998 Apr;170(4):969-75. doi: 10.2214/ajr.170.4.9530046.
The objective of this paper was to assess the safety and efficacy of percutaneous catheter drainage for initial treatment of infected acute necrotizing pancreatitis.
Thirty-four patients with acute necrotizing pancreatitis shown with contrast-enhanced CT were treated for sepsis with percutaneous catheter drainage. Extent of necrosis was less than 30% in 10 cases, 30-50% in 10 cases, and greater than 50% in 14 cases. Fourteen patients had central necrosis. Eighteen patients were critically ill with multiorgan failure.
Sixteen (47%) of the 34 patients were cured with only percutaneous catheter drainage, including four (29%) of the 14 patients with central gland necrosis and 12 (60%) of the 20 with body-tail necrosis. Sepsis was controlled (defervescence of fever and return of WBC to normal) in an additional nine patients, allowing elective pancreatic surgery for control of pancreatic duct fistula. Eight patients failed to show clinical improvement after drainage and required necrosectomy. No patient experienced catheter-related complications. Mortality was 12% (all four deaths occurred after necrosectomy because of multiorgan failure).
Percutaneous catheter drainage is a safe and effective technique for treating infected acute necrotizing pancreatitis. Overall, sepsis was controlled in 74% of patients, permitting elective surgery for treatment of pancreatic fistula, and 47% of patients were cured with no surgery required. No catheter-related complications occurred.
本文旨在评估经皮导管引流术作为感染性急性坏死性胰腺炎初始治疗方法的安全性和有效性。
34例经增强CT显示为急性坏死性胰腺炎的患者因脓毒症接受经皮导管引流治疗。坏死范围小于30%的有10例,30%-50%的有10例,大于50%的有14例。14例患者有胰腺中央坏死。18例患者病情危重,伴有多器官功能衰竭。
34例患者中有16例(47%)仅通过经皮导管引流治愈,其中14例胰腺中央坏死患者中有4例(29%),胰腺体尾部坏死的20例患者中有12例(60%)。另外9例患者的脓毒症得到控制(发热消退且白细胞恢复正常),从而可以择期进行胰腺手术以控制胰瘘。8例患者引流后未显示临床改善,需要进行坏死组织清除术。没有患者发生与导管相关的并发症。死亡率为12%(所有4例死亡均发生在坏死组织清除术后,原因是多器官功能衰竭)。
经皮导管引流术是治疗感染性急性坏死性胰腺炎的一种安全有效的技术。总体而言,74%的患者脓毒症得到控制,从而可以择期进行手术治疗胰瘘,47%的患者无需手术即被治愈。未发生与导管相关的并发症。